Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-12

Clinical Trial Update: AMH and Dosing Regimens for Initial IVF Stimulation Protocols [NA]

View source ↗

Summary

This completed clinical trial examined how anti-Müllerian hormone (AMH) may inform dosing regimens for initial IVF stimulation protocols.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-Müllerian hormone (AMH) (anti-Müllerian hormone)

Snippet

Sponsor: Reproductive Specialists of New York | Conditions: Infertility | NA | Status: COMPLETED